Quality of Life and Survival Outcome for Patients With Nasopharyngeal Carcinoma Receiving Three-Dimensional Conformal Radiotherapy vs. Intensity-Modulated Radiotherapy-A Longitudinal Study

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 2, 2008, Pages 356-364

  Fang, Fu Min ^a   Chien, Chih Yen ^a   Tsai, Wen Ling ^a,b   Chen, Hui Chun ^a   Hsu, Hsuan Chih ^a   Lui, Chun Chung ^a   Huang, Tai Lin ^a   Huang, Hsuan Ying ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b YUNG TA INSTITUTE OF TECHNOLOGY AND COMMERCE   (Taiwan)

Author keywords

EORTC; Intensity modulated radiotherapy; Nasopharyngeal carcinoma; Quality of life; Three dimensional conformal radiotherapy

Indexed keywords

EMERGENCY VEHICLES; FLUORESCENT SCREENS; PATIENT MONITORING; POINT GROUPS; RADIOTHERAPY; TELEVISION PICTURE TUBES;

EORTC; INTENSITY-MODULATED RADIOTHERAPY; NASOPHARYNGEAL CARCINOMA; QUALITY OF LIFE; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY;

THREE DIMENSIONAL;

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; FATIGUE; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; XEROSTOMIA;

ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 51649110432     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.12.054     Document Type: Article

References (36)

1. Teo P.M.L., Ma B.B.Y., and Chan A.T.C. Radiotherapy for nasopharyngeal carcinoma-transition from two-dimensional to three-dimensional methods. Radiother Oncol 73 (2004) 163-172
2. Jen Y.M., Shih R., Lin Y.S., et al. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: A dosimetric and clinical comparison with conventional radiotherapy. Radiother Oncol 75 (2005) 204-209
3. Chao K.S.C., Majhail N., Huang C.J., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 61 (2001) 275-280
4. Saarilahti K., Kouri M., Collan J., et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 74 (2005) 251-258
5. McMillan A.S., Pow E.H.N., Kwong D.L.W., et al. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: Results of a prospective longitudinal study. Head Neck 28 (2006) 712-722
6. Hsiung C.Y., Ting H.M., Huang H.Y., et al. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative scintigraphy and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 454-461
7. Fang F.M., Tsai W.L., Chen H.C., et al. Intensity-modulated or conformal radiotherapy improves quality of life of patients with nasopharyngeal carcinoma-comparisons of four radiotherapy techniques. Cancer 109 (2007) 311-321
8. Sultanem K., Shu H.K., Xia P., et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 48 (2000) 711-722
9. Xia P., Fu K.K., Wong G.W., et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 (2000) 329-337
10. Hsiung C.Y., Yorke E.D., Chui C.S., et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 53 (2002) 638-647
11. Fang F.M., Tsai W.L., Ko S.F., et al. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of RT. Int J Radiat Oncol Biol Phys 50 (2001) 961-969
12. Hsiung C.Y., Hunt M.A., Yorke E.D., et al. Intensity-modulated radiotherapy as the boost or salvage treatment of nasopharyngeal carcinoma: The appropriate parameters in the inverse planning and the effect of patient's anatomic factors on the planning results. Radiother Oncol 77 (2005) 53-57
13. Bjordal K., and Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 31 (1992) 311-321
14. Aronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
15. Bjordal K., Hammerlid E., Ahlner-Elmqvist M., et al. Quality of life in head and neck cancer patients: Validation of the EORTC H&N35. J Clin Oncol 17 (1999) 1008-1019
16. Fayers P., Aaronson N.K., Bjordal K., et al. EORTC QLQ-C30 scoring manual. 2nd edition (1999), EORTC Data Center, Brussels, Belgium
17. King M.T. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5 (1996) 555-567
18. Osoba D., Rodrigues G., Myles J., et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16 (1998) 139-144
19. Kwong D.L.W., Pow E.H.N., Sham J.S.T., et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer 101 (2004) 1584-1593
20. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
21. Wolden S.L., Chen W.C., Pfister D.G., et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
22. Wolden S.L., Zelefsky M.J., Hunt M.A., et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 49 (2001) 1229-1234
23. Fang F.M., Chiu H.C., Kuo W.R., et al. Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int J Radiat Oncol Biol Phys 53 (2002) 959-968
24. Sham J.S.T., and Wei W.I. Nasopharyngeal carcinoma. Lancet 365 (2005) 2041-2054
25. Kam M.K.M., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25 (2007) 4873-4879
26. List M.A., and Stracks J. Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. Curr Opin Oncol 12 (2000) 215-220
27. Hammerlid E., Mercke C., Sullivan M., et al. A prospective quality of life study of patients with laryngeal carcinoma by tumor stage and different radiation therapy schedules. Laryngoscope 108 (1998) 747-759
28. De Graeff A., de Leeuw J.R.J., Ros W.J.G., et al. A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck 21 (1999) 291-296
29. De Graeff A., de Leeuw J.R.J., Ros W.J.G., et al. Long-term quality of life of patients with head and neck cancer. Laryngoscope 110 (2000) 98-106
30. Bjordal K., Ahlner-Elmqvist M., Hammerlid E., et al. A prospective study of quality of life in head and neck cancer patients part II: Longitudinal data. Laryngoscope 111 (2001) 1440-1452
31. Hammerlid E., and Taft C. Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms. Br J Cancer 84 (2001) 149-156
32. Fisher J., Scott C., Scarantino C.W., et al. Phase III quality of life study: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer-RTOG 97-09. Int J Radiat Oncol Biol Phys 56 (2003) 832-836
33. Ringash J., Warde P., Lockwood G., O'Sullivan B., et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 61 (2005) 1403-1407
34. Sprangers M.A. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 41 (2002) 229-237
35. Sprangers M.A., and Schwartz C.E. Integrating response shift into health-related quality of life research: a theoretical model. Social Sci Med 48 (1999) 1507-1515
36. Cengiz M., Ozyar E., Esassolak M., et al. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 63 (2005) 1347-1353